Bayer is thriving in Finland

It’s ten years since Bayer acquired an R&D and manufacturing unit in Turku, Finland. Becoming the owner of the women’s healthcare business was the result of a major consolidation of the pharmaceutical sector, and perhaps a mere detail to Bayer at the time. But times change.

With a now committed owner and a truly global marketing and sales organization, demand for the Mirena family of intra-uterine devices grew rapidly. Sales are up ten-fold under Bayer’s ownership. By the end of 2015, Mirena sales reached the one billion euro run-rate. This milestone earns Turku’s Mirena “blockbuster” status – and, in that respect, a notable first for Finland.

Read the whole story at

Pia Mörk
comments powered by Disqus